← Leaderboards
Michael Brenner
University Of Alabama At Birmingham
$5,386,092
Attributed
$5,386,092
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $820.5K · FY2005–12$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$5,386,092 · 4
By mechanism
R01$2,575,884 · 1
P01$1,611,045 · 2
P30$1,199,163 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Bradley K. Yoder$32,312,462
- Scott Michael Wilson$6,208,421
- Ambika Pallikunnath Ashraf$713,140
- Barbara A. Gower$29,302,489
- Etty N. Benveniste$18,164,533
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsGlial Fibrillary Acidic ProteinBrainAstrocytesNeuronsResearch StudyResponseInvestigationGenesMutationNervous System DisorderAmyotrophic Lateral SclerosisTransfectionDesignAlexander DiseaseCellsCentral Nervous System DiseasesMolecularReporter GenesPhosphorylationLeukodystrophyLaboratory MouseBiochemistryGenetic Transcription
Grant awards (22)
Biochemistry and Genetics of Alexander Disease$335,381
P01 · FY2012 · NS · contact PI
Recombinant Technologies Core$255,632
P30 · FY2012 · HD · contact PI
Biochemistry and Genetics of Alexander Disease$314,281
P01 · FY2011 · NS · contact PI
Recombinant Technologies Core$253,554
P30 · FY2011 · HD · contact PI
Analyses and Applications of GFAP Transcription$355,341
R01 · FY2010 · NS · contact PI
Biochemistry and Genetics of Alexander Disease$235,992
P01 · FY2010 · NS · contact PI
Recombinant Technologies Core$229,138
P30 · FY2010 · HD · contact PI
Analyses and Applications of GFAP Transcription$358,930
R01 · FY2009 · NS · contact PI
Recombinant Technologies Core$225,962
P30 · FY2009 · HD · contact PI
Biochemistry and Genetics of Alexander Disease$120,044
P01 · FY2009 · NS · contact PI
Analyses and Applications of GFAP Transcription$358,930
R01 · FY2008 · NS · contact PI
Recombinant Technologies Core$234,877
P30 · FY2008 · HD · contact PI
Biochemistry and Genetics of Alexander Disease$122,949
P01 · FY2008 · NS · contact PI
Analyses and Applications of GFAP Transcription$20,000
R01 · FY2008 · NS · contact PI
Analyses and Applications of GFAP Transcription$358,930
R01 · FY2007 · NS · contact PI
Analyses and Applications of GFAP Transcription$195,506
R01 · FY2006 · NS · contact PI
Mutations and biochemistry of GFAP in Alexander Disease$482,398
P01 · FY2005 · NS
ANALYSES AND APPLICATIONS OF GLIAL FIBRILLARY ACIDIC PRO$241,800
R01 · FY2003 · NS
ANALYSES AND APPLICATIONS OF GLIAL FIBRILLARY ACIDIC PRO$234,759
R01 · FY2002 · NS
Mutations and biochemistry of GFAP in Alexander Disease$0
P01 · FY2002 · NS
ANALYSES AND APPLICATIONS OF GLIAL FIBRILLARY ACIDIC PRO$227,919
R01 · FY2001 · NS
ANALYSES AND APPLICATIONS OF GLIAL FIBRILLARY ACIDIC PRO$223,769
R01 · FY2000 · NS